Lymphoid Malignancies
In our division for lymphoid malignancies, we have centralized all lymphoid hematological diseases into one unit, which means we have a broad competence center for aggressive and indolent lymphomas, chronic lymphocytic leukemia (CLL), and acute lymphocytic leukemia (ALL).
This allows us to offer our patients the possibility to participate in several clinical studies with new therapies, such as bispecific antibodies and cellular therapy, in collaboration with our cell therapy unit at Karolinska. As the largest center for this in Sweden, we perform all sorts of treatments for lymphoid malignancies, including novel agents, intensive chemotherapy, and high-dose therapy with autologous stem cell transplantation and an extensive outpatient clinic.
Hematology
The Hematology Center at Karolinska is the largest of its kind in Sweden, and the collaboration between the center and the Karolinska Institutet ensures strong clinical and translational research. Hematology
Bringing together cutting-edge research and world-leading expertise